AI doctors, factory robots, and drones on the Great Wall: how China embraced artificial intelligence
While much of the West debates AI cautiously, China has woven it into daily life at speed, from millions of patients chatting with virtual doctors to state surveillance tools that watch city streets.
Key points
- Millions of people in China are already using AI-powered virtual doctors for medical consultations.
- Intelligent robots now work alongside humans on Chinese factory floors at significant scale.
- Food delivery drones operate at tourist sites including the Great Wall of China.
- The Chinese state has adopted AI surveillance tools as a central part of its monitoring infrastructure.
- Western countries have met the spread of AI with noticeably more public scepticism than China.
Picture a patient in Shanghai opening an app, typing symptoms, and getting a diagnosis from a digital avatar, a computer-generated doctor face that can listen, respond, and advise. No waiting room. No appointment. This is not a pilot programme. It is everyday life for millions of Chinese citizens.
That is the picture Amy Hawkins, senior China correspondent at The Guardian, painted in a recent interview about how thoroughly AI has settled into Chinese society.
The scale is hard to overstate. Factories run intelligent robots that adapt to the production line around them. Delivery drones, small autonomous aircraft that carry packages without a human pilot, drop food orders at spots along the Great Wall of China, one of the most visited tourist destinations on earth. Meanwhile, AI diagnostic tools, software trained to spot illness from symptoms or scans, handle consultations that in other countries would require a GP appointment weeks away.
Why does this matter to people outside China?
It matters because China is running the world's largest real-world test of AI in everyday life, and the results will shape how other governments and companies choose to move.
The speed of adoption points to something beyond technology. Chinese regulators have cleared AI health tools faster than their counterparts in the United States or Europe, where patient-safety frameworks move slowly and for good reason. A virtual doctor that gives wrong advice carries real consequences. Trial sizes, independent safety audits, and long-term outcome data are still largely absent from public reporting on these tools.
Then there is the surveillance question.
The same AI infrastructure that powers a helpful medical avatar also powers systems that track citizens' movements, flag dissent, and feed data to state security agencies. These are not separate programmes. They share technology, computing power, and government backing.
For patients, the trade-off is stark. Faster access to medical advice is genuinely valuable, especially in rural areas where doctors are scarce. But the data those consultations generate does not stay private in the way a Western patient might expect.
For the rest of the world watching, China's rollout is both a preview and a warning. The convenience is real. So are the risks that come when a government controls both the AI and the rules around it.
What is clear is that the gap between China's pace of AI adoption and the West's is widening. Whether that gap represents progress or peril depends almost entirely on who holds the data and who they answer to.
